PS
AMRX icon

Principal Securities’s Amneal Pharmaceuticals AMRX Stock Holding History

Principal Securities’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$131K Buy
+10,543
New +$142K ﹤0.01% 1401
2025
Q4 		– Sell
-2,170
Closed -$21.7K – 1437
2025
Q3 		$21.7K Buy
+2,170
New +$19.5K ﹤0.01% 2367

Other funds holding AMRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Principal Securities's AMRX Position: Q1 2026 in Review

Principal Securities opened a new position in Amneal Pharmaceuticals (AMRX) in Q1 2026: 10,543 shares worth $131K. The stake represents ﹤0.01% of the portfolio and ranks #1401 among its holdings. This is a return to the name: Principal Securities previously reported a position in AMRX as recently as Q3 2025.

Principal Securities first reported a position in AMRX in Q3 2025 and has held it in 2 quarters since. 315 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • Principal Securities held 10,543 shares of Amneal Pharmaceuticals worth $131K as of Q1 2026.
  • Amneal Pharmaceuticals was a new Principal Securities position in Q1 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of Principal Securities's portfolio in Q1 2026, its #1401 holding.
  • Principal Securities first reported a position in Amneal Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • 315 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Principal Securities's 13F filing for Q1 2026, filed 13 May 2026.